In the News

52 News Items found
Memorial Sloan Kettering physician-scientist Michel Sadelain.
A gene therapy approach could prove effective at treating an inherited blood disorder called beta (β)-thalassemia.
Dr. Michael Overholtzer
Feature
Seventeen scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 17, 2023, as part of Memorial Sloan Kettering’s 44th annual academic convocation.